… Enhertu, AstraZeneca and Daiichi Sankyo’s blockbuster HER2 cancer … raising the possibility that Daiichi Sankyo will have competing products … oncology clinical development at Daiichi Sankyo, discussed how that … AstraZeneca, said on an earnings call in November. …

… accelerated approval. AstraZeneca and Daiichi Sankyo are currently investigating the … after releasing its Q3 earnings report Tuesday, reporting a … 57 billion.  AstraZeneca’s earnings were boosted by its … He added that core earnings per share (EPS) were …

… report its third-quarter 2024 earnings Tuesday morning, and the company … of high-performing drugs. Adjusted earnings per ADR (equivalent to two … . Enhertu, developed in collaboration with Daiichi Sankyo, showed exceptional growth at 46% …

… NASDAQ:ESPR) Q3 2024 Earnings Call Transcript November 7, … Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is … s third quarter 2024 earnings conference call. With … Europe, our partner, Daiichi Sankyo Company, Limited, gained approval …

… undisclosed neurodegeneration and oncology targets. Daiichi Sankyo announced it will pay Merck … net loss and lower underlying earnings, dragged by its crop-science …

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q1 2024 Earnings Conference Call July 31, … unrealized gains of inventory for Daiichi Sankyo Espha products. So revenue … biomarker preparations. AstraZeneca and Daiichi Sankyo are currently deepening discussions on …

… third-quarter revenue and adjusted earnings that topped expectations as the … deals with Curon Biopharmaceutical and Daiichi Sankyo.  Here's what Merck … survey of analysts by LSEG:  Earnings per share: $1.57 adjusted …

… SE (PNK:DASTY) Q3 2024 Earnings Call Transcript October 24, 2024 … that expanded relationships, Otsuka, Merck, Daiichi Sankyo, Revolution Medicines, Immunovent, Ipsen, BeiGene …

… Therapeutics, Inc. misses on earnings expectations. Reported EPS is $- … ’s Second Quarter 2024 Earnings Conference Call. At this … ’s second quarter 2024 earnings conference call. With us … . Beyond Europe, our partner, Daiichi Sankyo Company Limited, or DS ASCA …

… amp; Co. Q2 sales and earnings conference call. [Operator instructions] This … These slides, along with the earnings release, today's … 14.1%. Taken together, earnings per share were $2.28 … . Last month, together with Daiichi Sankyo, we announced receipt of a …